Obesity as A Risk Factor for Breast Cancer and Its Prognosis: Systematic Review
Life Sciences-Medicine
DOI:
https://doi.org/10.22376/ijlpr.2023.13.1.SP2.L1-L8Keywords:
reast Cancer, Tumor, Obesity, Overweight, BMI, MalignancyAbstract
Abstract: Obesity is a significant public health issue, particularly in developed countries such as the United States, where more than 36% of adults are obese. Understanding how obesity affects breast cancer is essential for public health because it is the most common cancer and the second leading cause of cancer death among women in developed countries. Numerous studies show a significantly more vital link between increased body mass index (BMI) and breast cancer incidence. Furthermore, obese women with breast cancer have a higher risk of all-cause and breast cancer-specific mortality than non-obese women. A better understanding of the relationship between obesity and breast cancer is critical because this patient population has unique diagnostic and treatment challenges. The study aims to summarize current evidence regarding the association between obesity and breast cancer as a risk factor and its effect on patients' prognosis. For article selection, the PubMed database and EBSCO Information Services were used. All relevant articles relevant to our topic and other articles were used in our review. Other articles that were not related to this field were excluded. The data was extracted in a specific format that the group members reviewed. Our study included nine studies, all of which indicated a positive correlation with different types of breast cancer as a risk factor. One study reported no effect on prognosis.
References
World Health Organization. Obesity and overweight. Fact Sheet 311 [cited May 2014]. Geneva, Switzerland: World Health Organization; 2014.
Kumar V, Abbas AK, Fausto N, Aster J. 8th ed. Elsevier; Philadelphia: 2010. Robbins and Cotran. Pathologic basis of disease; pp. 259-330. 1065-1095.
Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15(6):556-65. doi: 10.1634/theoncologist.2009-0285, PMID 20507889.
Peeters A. Increasing BMI was associated with increasing risk for overall cancer incidence and mortality in middle-aged women. ACP J Club. 2008;148(3):13. PMID 18489076.
De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546. doi: 10.1155/2013/291546, PMID 24073332.
Liu K, Zhang W, Dai Z, Wang M, Tian T, Liu X et al. Association between body mass index and breast cancer risk: evidence based on a dose–response meta-analysis. Cancer Manag Res. 2018;10:143-51. doi: 10.2147/CMAR.S144619, PMID 29403312.
Iyengar NM, Arthur R, Manson JE. Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: a secondary analysis of a randomized clinical trial and observational study. JAMA Oncol. 2018;5(2):155-63.
Mohanty SS, Mohanty PK. Obesity as potential breast cancer risk factor for postmenopausal women. Genes Dis. 2021;8(2):117-23. doi: 10.1016/j.gendis.2019.09.006, PMID 33997158.
Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M et al. Risk determination and prevention of breast cancer. Breast Cancer Res. 2014;16(5):446. doi: 10.1186/s13058-014-0446-2, PMID 25467785.
Food, nutrition, physical activity, and the prevention of cancer: A global perspective [cited Aug 15 2013]. Available from: http://www.dietandcancerreport.org/expert_report/report_contents/index.php.
Nattenmüller CJ, Kriegsmann M, Sookthai D, Fortner RT, Steffen A, Walter B et al. Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study. BMC Cancer. May 31. 2018;18(1):616. doi: 10.1186/s12885-018-4548-6, PMID 29855282.
Tan X, Huang D, Zhang F, Zhao Y, Tan M, Li H et al. Evaluation of the body mass index in breast cancer prognosis in a cohort of small-stature overweight patients: multi-center study in China. Gland Surg. 2021;10(1):23-34. doi: 10.21037/gs-20-488, PMID 33633959.
Moore AH, Trentham-Dietz A, Burns M, Gangnon RE, Greenberg CC, Vanness D.J. et al. Holliston et al. Obesity and mortality after locoregional breast cancer diagnosis. Breast Cancer Res Treat. 2018;172(3):647-57. doi: 10.1007/s10549-018-4932-6, PMID 30159788.
Al Jarroudi O, Abda N, Seddik Y, Brahmi SA, Afqir S. Overweight: is it a prognostic factor in women with triple-negative breast cancer? Asian Pac J Cancer Prev. Jun 25 2017;18(6):1519-23. doi: 10.22034/APJCP.2017.18.6.1519, PMID 28669161.
Gravena AAF, Romeiro Lopes TC, Demitto MO, Borghesan DHP, Dell’ Agnolo CM, Brischiliari SCR et al. The obesity and the risk of breast cancer among Pre and postmenopausal women. Asian Pac J Cancer Prev. Sep 26 2018;19(9):2429-36. doi: 10.22034/APJCP.2018.19.9.2429, PMID 30255696.
Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: A secondary analysis of the Women’s Health Initiative randomized clinical trials. JAMA Oncol. 2015;1(5):611-21. doi: 10.1001/jamaoncol.2015.1546, PMID 26182172.
Swerdlow AJ, Bruce C, Cooke R, Coulson P, Griffin J, Butlin A et al. Obesity and breast cancer risk in men: A national case-control study in England and Wales. JNCI Cancer Spectr. Aug 28 2021;5(5). doi: 10.1093/jncics/pkab078, PMID 34738071.
Park JW, Han K, Shin DW, Yeo Y, Chang JW, Yoo JE et al. Obesity and breast cancer risk for pre- and postmenopausal women among over 6 million Korean women. Breast Cancer Res Treat. 2021;185(2):495-506. doi: 10.1007/s10549-020-05952-4, PMID 33010023.
Park B, Kim S, Kim H, Cha C, Chung MS. Associations between obesity, metabolic health, and the risk of breast cancer in East Asian women. Br J Cancer. 2021;125(12):1718-25. doi: 10.1038/s41416-021-01540-5, PMID 34552203.
Brown KA. Metabolic pathways in obesity-related breast cancer. Nat Rev Endocrinol. 2021;17(6):350-63. doi: 10.1038/s41574-021-00487-0, PMID 33927368.
Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief. 2015;201(219):1-8. PMID 26633046.
Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med. 2006;166(21):2395-402. doi: 10.1001/archinte.166.21.2395, PMID 17130395.
Berstad P, Coates RJ, Bernstein L, Folger SG, Malone KE, Marchbanks PA, et al. A case‐control study of body mass index and breast cancer risk in white and African‐American women. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1532-44. doi: 10.1158/1055-9965.EPI-10-0025, PMID 20501755.
White AJ, Nichols HB, Bradshaw PT, Sandler DP. Overall and central adiposity and breast cancer risk in the Sister Study. Cancer. 2015;121(20):3700-8. doi: 10.1002/cncr.29552, PMID 26193782.
Harris HR, Willett WC, Terry KL, Michels KB. Body fat distribution and risk of premenopausal breast cancer in the Nurses’ Health Study II. J Natl Cancer Inst. 2011;103(3):273-8. doi: 10.1093/jnci/djq500, PMID 21163903.
van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514-27. doi: 10.1093/aje/152.6.514, PMID 10997541.
Bergström A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91(3):421-30. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1053>3.0.co;2-t, PMID 11169969.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569-78. doi: 10.1016/S0140-6736(08)60269-X, PMID 18280327.
Kawai M, Malone KE, Tang MT, Li CI. Height, body mass index (BMI), BMI change, and the risk of estrogen receptor‐positive, HER2‐positive, and triple‐negative breast cancer among women ages 20 to 44 years. Cancer. 2014;120(10):1548-56. doi: 10.1002/cncr.28601, PMID 24500704.
Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land S.R., et al. Body mass index and the risk for developing invasive breast cancer among high‐risk women in NSABP P‐1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila). 2012;5(4):583-92. doi: 10.1158/1940-6207.CAPR-11-0482, PMID 22318751.
Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose‐response meta-analysis. Obes Rev. 2013;14(8):665-78. doi: 10.1111/obr.12028, PMID 23615120.
Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629-36. doi: 10.1161/ATVBAHA.107.151092, PMID 18174459.
Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case‐control study. Nutr Metab Cardiovasc Dis. 2010;20(1):41-8. doi: 10.1016/j.numecd.2009.02.006, PMID 19361966.
Li CI, Malone KE, Daling JR. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States). Cancer Causes Control. 2006;17(5):695-703. doi: 10.1007/s10552-005-0001-7, PMID 16633917.
Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the Women’s Health Initiative randomized clinical trials. JAMA Oncol. 2015;1(5):611-21. doi: 10.1001/jamaoncol.2015.1546, PMID 26182172.
Sebastiani F, Cortesi L, Sant M, Lucarini V, Cirilli C, De Matteis E, et al. Increased incidence of breast cancer in postmenopausal women with high body mass index at the Modena Screening Program. J Breast Cancer. 2016;19(3):283-91. doi: 10.4048/jbc.2016.19.3.283, PMID 27721878.
Bhaskaran K, Douglas I, Forbes H, dos‐Santos‐Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population‐based cohort study of 5.24 million U.K. adults. Lancet. 2014;384(9945):755-65. doi: 10.1016/S0140-6736(14)60892-8, PMID 25129328.
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134. doi: 10.1136/bmj.39367.495995. A.E., PMID 17986716.
Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2004;111(5):762-71. doi: 10.1002/ijc.20315, PMID 15252848, Google Scholar.
Klintman M, Rosendahl AH, Randeris B, Eriksson M, Czene K, Hall P et al. Postmenopausal overweight and breast cancer risk; results from the KARMA cohort. Breast Cancer Res Treat. 2022;196(1):185-96. doi: 10.1007/s10549-022-06664-7, PMID 36040641.
Ahn J, Schatzkin A, Lacey JV Jr, Albanes D, Ballard-Barbash R, Adams KF, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med. 2007;167(19):2091-102. doi: 10.1001/archinte.167.19.2091, PMID 17954804.
Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S. Hormonal factors and the risk of breast cancer according to estrogen‐ and progesterone‐receptor subgroup. Cancer Epidemiol Biomarkers Prev. 2003;12(10):1053-60. PMID 14578142.
Ma H, Bernstein L, Ross RK, Ursin G. Hormone‐related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case‐control and a case‐case comparison [serial online]. Breast Cancer Res. 2006;8(4):R39. doi: 10.1186/bcr1514, PMID 16846528.
John EM, Sangaramoorthy M, Hines LM, Stern MC, Baumgartner KB, Giuliano AR, et al. Overall and abdominal adiposity and premenopausal breast cancer risk among Hispanic women: the Breast Cancer Health Disparities study. Cancer Epidemiol Biomarkers Prev. 2015;24(1):138-47. doi: 10.1158/1055-9965.EPI-13-1007-T, PMID 25352526.
Nagrani R, Mhatre S, Rajaraman P, Soerjomataram I, Boffetta P, Gupta S, et al. Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian ethnicity. Eur J Cancer. 2016;66:153-61. doi: 10.1016/j.ejca.2016.07.022, PMID 27573429.
Enger SM, Ross RK, Paganini‐Hill A, Carpenter CL, Bernstein L. Body size, physical activity, and breast cancer hormone receptor status: results from two case‐control studies. Cancer Epidemiol Biomarkers Prev. 2000;9(7):681-7. PMID 10919738.
Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, et al. Risk factors by molecular subtypes of breast cancer across a population‐based study of women 56 years or younger. Breast Cancer Res Treat. 2011;130(2):587-97. doi: 10.1007/s10549-011-1616-x, PMID 21667121.
Suzuki R, Rylander‐Rudqvist T, Ye W, Saji S, Wolk A. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: a prospective cohort study. Int J Cancer. 2006;119(7):1683-9. doi: 10.1002/ijc.22034, PMID 16646051.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Khulud Sughayyer Naif Alanazi, Rawan Dubas Alanazi, Almagd Mtap N Alanzai, Ayashah Moulfi Alhazmi, Rasha zaki A Alruwaili, Asma Saleh S Alruwaili, Eman Mazyad alruwaili, Amjad Mofareh S Alruwaili, Ghzl Ghazi Alenezi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
